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First 100 Cases of BLS First Responder Administered Naloxone in a
Statewide EMS System
J. Markman MBA1, T. Koedam MD2, J. Mastenbrook MD2, W. Fales MD2
1Michigan

BACKGROUND
Michigan Public Act 312 approved by State House -- Oct 14, 2014
• 3rd state to mandate implementation among fire departments
Fire departments & municipality objections :
• Unfunded mandate for training and medication maintenance
• Concern from fire community about diverted training time
Medical community objections:
• “With a hammer, everything looks like a nail” effect
• Is naloxone administered inappropriately in lieu of proper PPV
• PPV treats respiratory depression of opioid overdose, so why
complicate?
• Redundancy as ALS does this already & usually arrives promptly
Significant public interest and positive media coverage regarding first
responder naloxone

STATE NALOXONE PROTOCOL
•
•
•
•
•
•

Known or suspected opiod overdose patient not in cardiac arrest
Administered after PPV established
Purpose to counter resipratory depression, not improve alertness
Two first responders on scene for safety
ALS arrival >5 minutes
No nasal trauma, epistaxis, or cocaine usage

PURPOSE
We sought to evaluate the first 100 Michigan first responder naloxone
administrations for medical appropriateness and protocol adherence:
•
Does naloxone displace emphasis on early PPV?
•
Is naloxone being administered to appropriate patients?
•
Does the mandate save patients who would not receive ALS in
time?
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First Responder Bias Affects Protocol Compliance
No Known Drug Abuse

Known Drug Abuse

No PPV
38%

PPV
39%

No PPV
61%
PPV
62%

Naloxone Administered During Cardiac Arrest
Cardiac
Arrest
10%

No Cardiac
Arrest
90%

Naloxone Often Administered When Not Indicated
Medically
Indicated
77%
Not Medically
Indicated
23%

METHODS
•
•
•
•
•
•
•

Retrospective chart review
Utilized MI-EMSIS – a statewide EMS information system database
Filtered on “naloxone” as a medication administered
Began with mandatory implementation date of 10/15/2015
Selected first 100 cases that met inclusion criteria
Three investigator panel evaluated medical appropriateness
Data abstracted from each case:
• Initial impression of mental and respiratory status
• Airway interventions attempted
• Known history of opioid abuse
• Timing of ALS arrival
• Data were analyzed using standard descriptive statistics

Most Naloxone Administered Within 5 min of ALS*

ALS < 5 min.
69%

ALS > 5 min.
31%

RESULTS
•
•
•
•

71% male
Ages 18-89, Mean 37, Median 35, Mode 23
66% known positive drug history
75% of naloxone administrations were in patients with a pulse with an
inadequate respiratory rate
• Of patients needing PPVs, 51.3% received PPVs prior to naloxone
administration
• ALS arrival was reported to be <5 minutes in 38% of cases, >5
minutes in 17% of cases, and was not mentioned in 57% of BLS First
Responder Agency records included in this study

DISCUSSION
• This study is the first to evaluate a statewide naloxone mandate
• In light of skyrocketing opioid overdose deaths, a great deal of political
enthusiasm surrounds first responder naloxone use, yet little evidence
exists to support that these mandates improve patient outcome.
• Our data suggest that insufficient emphasis has been placed on
adherence & integration of naloxone protocols.
• First responder naloxone is frequently redundant with already
available ALS naloxone and no patient deaths were noted to be
associated with BLS not administering naloxone.

CONCLUSION
• Adherence to the state naloxone protocol appears poor
• The majority of patients given naloxone had inadequate
respiratory rate
• Naloxone was frequently administered before PPV
• Known drug abuse history significantly affected first responder
treatment behavior. PPV was not administered prior to naloxone
as readily in these patients
• When documented, the majority of naloxone administrations
occured within 5 minutes ALS arrival

LIMITATIONS
• MI-EMSIS is not a registry
• Inconsistency of quantity and quality of data elements among
records
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* Of cases reporting ALS arrival

